{"entity":{"type":"insider","cik":"0001643653","url":"/insider/0001643653","json_url":"/insider/0001643653.json","name":"BENEVICH ERIC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":60,"n_filings":35,"first":"2017-02-08","last":"2025-12-02","span_basis":"filed_date"},"name_variants":[{"name":"BENEVICH ERIC","source":"filing","n_filings":35,"first_seen":"2017-02-08","last_seen":"2025-12-02"}],"transactions":[{"id":4047040,"accession":"0001643653-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001643653-25-000007","line_url":"/filing/0001643653-25-000007#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5970.0,"shares_display":"5,970","price_per_share":151.7388,"price_display":"151.74","price_state":"stated","total_value":905880.636,"total_display":"905,880.64","total_whole":"905,881","shares_owned_after":44893.0,"shares_owned_after_display":"44,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-28","filed_date":"2025-12-02","scope":"insider"},{"id":4452825,"accession":"0000914475-25-000057","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-25-000057","line_url":"/filing/0000914475-25-000057","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2154.0,"shares_display":"2,154","price_per_share":116.7259217270195,"price_display":"116.73","price_state":"stated","total_value":251427.6354,"total_display":"251,427.64","total_whole":"251,428","shares_owned_after":43784.0,"shares_owned_after_display":"43,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider","n_lines":2},{"id":4162290,"accession":"0000914475-25-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000047","line_url":"/filing/0000914475-25-000047#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":118.3065,"price_display":"118.31","price_state":"stated","total_value":115940.37,"total_display":"115,940.37","total_whole":"115,940","shares_owned_after":42799.0,"shares_owned_after_display":"42,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":4043182,"accession":"0000914475-25-000021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000021","line_url":"/filing/0000914475-25-000021#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1207.0,"shares_display":"1,207","price_per_share":152.94,"price_display":"152.94","price_state":"stated","total_value":184598.58,"total_display":"184,598.58","total_whole":"184,599","shares_owned_after":41919.0,"shares_owned_after_display":"41,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-04","scope":"insider"},{"id":3067232,"accession":"0000914475-24-000111","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-24-000111","line_url":"/filing/0000914475-24-000111","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19818.0,"shares_display":"19,818","price_per_share":133.3646,"price_display":"133.36","price_state":"stated","total_value":2643019.6428,"total_display":"2,643,019.64","total_whole":"2,643,020","shares_owned_after":40778.0,"shares_owned_after_display":"40,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-15","filed_date":"2024-04-17","scope":"insider","n_lines":2},{"id":2380573,"accession":"0000914475-24-000096","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-24-000096","line_url":"/filing/0000914475-24-000096","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":139.3789,"price_display":"139.38","price_state":"stated","total_value":10453417.5,"total_display":"10,453,417.50","total_whole":"10,453,418","shares_owned_after":40778.0,"shares_owned_after_display":"40,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider","n_lines":2},{"id":3200048,"accession":"0000914475-24-000082","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-24-000082","line_url":"/filing/0000914475-24-000082","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":134.6881,"price_display":"134.69","price_state":"stated","total_value":10101607.5,"total_display":"10,101,607.50","total_whole":"10,101,608","shares_owned_after":40616.0,"shares_owned_after_display":"40,616","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-02-29","scope":"insider","n_lines":2},{"id":2537027,"accession":"0000914475-24-000068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000068","line_url":"/filing/0000914475-24-000068#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1098.0,"shares_display":"1,098","price_per_share":133.0149,"price_display":"133.01","price_state":"stated","total_value":146050.3602,"total_display":"146,050.36","total_whole":"146,050","shares_owned_after":40616.0,"shares_owned_after_display":"40,616","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":2338692,"accession":"0000914475-24-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000044","line_url":"/filing/0000914475-24-000044#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":134.1925,"price_display":"134.19","price_state":"stated","total_value":131508.65,"total_display":"131,508.65","total_whole":"131,509","shares_owned_after":39631.0,"shares_owned_after_display":"39,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-08","filed_date":"2024-02-08","scope":"insider"},{"id":2338684,"accession":"0000914475-24-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000044","line_url":"/filing/0000914475-24-000044#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1280.0,"shares_display":"1,280","price_per_share":142.1172,"price_display":"142.12","price_state":"stated","total_value":181910.016,"total_display":"181,910.02","total_whole":"181,910","shares_owned_after":38751.0,"shares_owned_after_display":"38,751","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":2942239,"accession":"0000914475-24-000023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000023","line_url":"/filing/0000914475-24-000023#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1207.0,"shares_display":"1,207","price_per_share":140.7844,"price_display":"140.78","price_state":"stated","total_value":169926.7708,"total_display":"169,926.77","total_whole":"169,927","shares_owned_after":37601.0,"shares_owned_after_display":"37,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"},{"id":8155368,"accession":"0001209191-23-047128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047128","line_url":"/filing/0001209191-23-047128#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":107.3975,"price_display":"107.40","price_state":"stated","total_value":171836.0,"total_display":"171,836.00","total_whole":"171,836","shares_owned_after":36436.0,"shares_owned_after_display":"36,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":8543148,"accession":"0001209191-23-007907","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-007907","line_url":"/filing/0001209191-23-007907#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":104.1184,"price_display":"104.12","price_state":"stated","total_value":102036.032,"total_display":"102,036.03","total_whole":"102,036","shares_owned_after":34381.0,"shares_owned_after_display":"34,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-08","scope":"insider"},{"id":8543142,"accession":"0001209191-23-007907","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-007907","line_url":"/filing/0001209191-23-007907","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17390.0,"shares_display":"17,390","price_per_share":102.4075891891892,"price_display":"102.41","price_state":"stated","total_value":1780867.976,"total_display":"1,780,867.98","total_whole":"1,780,868","shares_owned_after":33501.0,"shares_owned_after_display":"33,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-07","filed_date":"2023-02-08","scope":"insider","n_lines":2},{"id":8543133,"accession":"0001209191-23-007907","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007907","line_url":"/filing/0001209191-23-007907#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1280.0,"shares_display":"1,280","price_per_share":105.6256,"price_display":"105.63","price_state":"stated","total_value":135200.768,"total_display":"135,200.77","total_whole":"135,201","shares_owned_after":17879.0,"shares_owned_after_display":"17,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider"},{"id":8701260,"accession":"0001209191-23-006259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-006259","line_url":"/filing/0001209191-23-006259#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1207.0,"shares_display":"1,207","price_per_share":109.9505,"price_display":"109.95","price_state":"stated","total_value":132710.2535,"total_display":"132,710.25","total_whole":"132,710","shares_owned_after":16729.0,"shares_owned_after_display":"16,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider"},{"id":8018356,"accession":"0001209191-23-002829","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002829","line_url":"/filing/0001209191-23-002829#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":125.0,"price_display":"125.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":15643.0,"shares_owned_after_display":"15,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-06","filed_date":"2023-01-10","scope":"insider"},{"id":6150376,"accession":"0001209191-22-059245","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-059245","line_url":"/filing/0001209191-22-059245","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":125.9017,"price_display":"125.90","price_state":"stated","total_value":6295085.0,"total_display":"6,295,085.00","total_whole":"6,295,085","shares_owned_after":15643.0,"shares_owned_after_display":"15,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-30","filed_date":"2022-12-01","scope":"insider","n_lines":3},{"id":6926900,"accession":"0001209191-22-056437","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-056437","line_url":"/filing/0001209191-22-056437#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":125.362,"price_display":"125.36","price_state":"stated","total_value":12536.2,"total_display":"12,536.20","total_whole":"12,536","shares_owned_after":15643.0,"shares_owned_after_display":"15,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-10","filed_date":"2022-11-10","scope":"insider"},{"id":6926895,"accession":"0001209191-22-056437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-056437","line_url":"/filing/0001209191-22-056437#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24593.0,"shares_display":"24,593","price_per_share":125.3332,"price_display":"125.33","price_state":"stated","total_value":3082319.3876,"total_display":"3,082,319.39","total_whole":"3,082,319","shares_owned_after":15643.0,"shares_owned_after_display":"15,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-08","filed_date":"2022-11-10","scope":"insider"},{"id":6988085,"accession":"0001209191-22-055817","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-055817","line_url":"/filing/0001209191-22-055817#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8968.0,"shares_display":"8,968","price_per_share":125.0204,"price_display":"125.02","price_state":"stated","total_value":1121182.9472,"total_display":"1,121,182.95","total_whole":"1,121,183","shares_owned_after":15643.0,"shares_owned_after_display":"15,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-11-04","scope":"insider"},{"id":6988080,"accession":"0001209191-22-055817","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-055817","line_url":"/filing/0001209191-22-055817#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":125.0,"price_display":"125.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","total_whole":"50,000","shares_owned_after":15643.0,"shares_owned_after_display":"15,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-04","scope":"insider"},{"id":6987969,"accession":"0001209191-22-054117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054117","line_url":"/filing/0001209191-22-054117#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4960.0,"shares_display":"4,960","price_per_share":110.8229,"price_display":"110.82","price_state":"stated","total_value":549681.584,"total_display":"549,681.58","total_whole":"549,682","shares_owned_after":15643.0,"shares_owned_after_display":"15,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-17","filed_date":"2022-10-19","scope":"insider"},{"id":6693239,"accession":"0001209191-22-008204","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-008204","line_url":"/filing/0001209191-22-008204#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":79.6659,"price_display":"79.67","price_state":"stated","total_value":78072.582,"total_display":"78,072.58","total_whole":"78,073","shares_owned_after":20338.0,"shares_owned_after_display":"20,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-09","scope":"insider"},{"id":6693237,"accession":"0001209191-22-008204","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-008204","line_url":"/filing/0001209191-22-008204","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4119.0,"shares_display":"4,119","price_per_share":80.78376020878854,"price_display":"80.78","price_state":"stated","total_value":332748.3083,"total_display":"332,748.31","total_whole":"332,748","shares_owned_after":18309.0,"shares_owned_after_display":"18,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider","n_lines":3},{"id":5429841,"accession":"0001209191-21-052337","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-052337","line_url":"/filing/0001209191-21-052337#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5628.0,"shares_display":"5,628","price_per_share":89.6224,"price_display":"89.62","price_state":"stated","total_value":504394.8672,"total_display":"504,394.87","total_whole":"504,395","shares_owned_after":15608.0,"shares_owned_after_display":"15,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-18","scope":"insider"},{"id":4176707,"accession":"0001209191-21-009128","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-009128","line_url":"/filing/0001209191-21-009128","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4270.0,"shares_display":"4,270","price_per_share":116.82474355971897,"price_display":"116.82","price_state":"stated","total_value":498841.655,"total_display":"498,841.66","total_whole":"498,842","shares_owned_after":21099.0,"shares_owned_after_display":"21,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider","n_lines":3},{"id":4176698,"accession":"0001209191-21-009128","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-009128","line_url":"/filing/0001209191-21-009128#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":809.0,"shares_display":"809","price_per_share":114.026,"price_display":"114.03","price_state":"stated","total_value":92247.034,"total_display":"92,247.03","total_whole":"92,247","shares_owned_after":16434.0,"shares_owned_after_display":"16,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-09","scope":"insider"},{"id":4657630,"accession":"0001209191-21-005797","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-005797","line_url":"/filing/0001209191-21-005797","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":120.0,"price_display":"120.00","price_state":"stated","total_value":48000.0,"total_display":"48,000.00","total_whole":"48,000","shares_owned_after":15805.0,"shares_owned_after_display":"15,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-27","scope":"insider","n_lines":2},{"id":4657610,"accession":"0001209191-21-005797","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-005797","line_url":"/filing/0001209191-21-005797","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5077.0,"shares_display":"5,077","price_per_share":120.02585635217648,"price_display":"120.03","price_state":"stated","total_value":609371.2727,"total_display":"609,371.27","total_whole":"609,371","shares_owned_after":17405.0,"shares_owned_after_display":"17,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider","n_lines":2},{"id":2382937,"accession":"0001209191-20-058554","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-058554","line_url":"/filing/0001209191-20-058554#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":90.7058,"price_display":"90.71","price_state":"stated","total_value":204722.9906,"total_display":"204,722.99","total_whole":"204,723","shares_owned_after":17405.0,"shares_owned_after_display":"17,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-16","scope":"insider"},{"id":2145929,"accession":"0001209191-20-056981","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-056981","line_url":"/filing/0001209191-20-056981#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20595.0,"shares_display":"20,595","price_per_share":96.5269,"price_display":"96.53","price_state":"stated","total_value":1987971.5055,"total_display":"1,987,971.51","total_whole":"1,987,972","shares_owned_after":15374.0,"shares_owned_after_display":"15,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-04","scope":"insider"},{"id":3116001,"accession":"0001209191-20-045725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-045725","line_url":"/filing/0001209191-20-045725#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":118.8543,"price_display":"118.85","price_state":"stated","total_value":268254.1551,"total_display":"268,254.16","total_whole":"268,254","shares_owned_after":15374.0,"shares_owned_after_display":"15,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-07","scope":"insider"},{"id":2681898,"accession":"0001209191-20-026063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-026063","line_url":"/filing/0001209191-20-026063#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1934.0,"shares_display":"1,934","price_per_share":99.4508,"price_display":"99.45","price_state":"stated","total_value":192337.8472,"total_display":"192,337.85","total_whole":"192,338","shares_owned_after":13344.0,"shares_owned_after_display":"13,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-24","filed_date":"2020-04-28","scope":"insider"},{"id":2897393,"accession":"0001209191-20-025028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-025028","line_url":"/filing/0001209191-20-025028#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8632.0,"shares_display":"8,632","price_per_share":94.6499,"price_display":"94.65","price_state":"stated","total_value":817017.9368,"total_display":"817,017.94","total_whole":"817,018","shares_owned_after":11603.0,"shares_owned_after_display":"11,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-15","filed_date":"2020-04-17","scope":"insider"},{"id":2412997,"accession":"0001209191-20-008481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-008481","line_url":"/filing/0001209191-20-008481#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2030.0,"shares_display":"2,030","price_per_share":103.3238,"price_display":"103.32","price_state":"stated","total_value":209747.314,"total_display":"209,747.31","total_whole":"209,747","shares_owned_after":20087.0,"shares_owned_after_display":"20,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-07","filed_date":"2020-02-11","scope":"insider"},{"id":3188244,"accession":"0001209191-20-007671","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-007671","line_url":"/filing/0001209191-20-007671#line-3","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001643653","owner_name":"BENEVICH ERIC","owner_display_name":"BENEVICH ERIC","owner_url":"/insider/0001643653","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1395.0,"shares_display":"1,395","price_per_share":101.4773,"price_display":"101.48","price_state":"stated","total_value":141560.8335,"total_display":"141,560.83","total_whole":"141,561","shares_owned_after":18262.0,"shares_owned_after_display":"18,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-06","filed_date":"2020-02-07","scope":"insider"}],"collapsed":true,"next_cursor":"2020-02-06|3188244","ledger_fault":false,"count":{"value":60,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":60,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":60},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000914475","name":"NEUROCRINE BIOSCIENCES INC","url":"/issuer/0000914475","role":"Officer (Chief Commercial Officer)","n_filings":35,"first_seen":"2017-02-08","last_seen":"2025-12-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001643653","retrieved_at":"2026-08-25T21:50:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}